Antibiotic drop efficacy trial

Phase 3

Completed

• Conditions: Contact lens wear; Eye - Normal eye development and function

• Registration Number: ACTRN12610000920099
• Lead Sponsor: Brien Holden Vision Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-10-29
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 240

Inclusion Criteria

Be able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent,
Be male and at least 18 years old,
Be willing to comply with the wearing and clinical trial visit schedule as directed by the investigator,
Have ocular health findings considered to be normal” and which would not prevent the participant from safely wearing contact lenses / spectacles,
Have vision correctable to at least 6/12 (20/40) or better in each eye with contact lenses / spectacles,
Be experienced or may be inexperienced at wearing contact lenses

Exclusion Criteria

Any pre-existing ocular irritation, injury or condition that would preclude contact lens fitting,
Had eye surgery within 12 weeks immediately prior to enrolment for this trial,
Undergone previous corneal refractive surgery,
Contraindications to contact lens wear,
Allergy or intolerance to moxifloxacin or other quinolones/fluoroquinolones,
Be currently enrolled in another clinical trial or participation in a clinical trial within the previous 2 weeks for longer-term studies and 48 hours between short-term studies,
Female are excluded from this trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified